• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加强全球卫生韧性:马尔堡病毒样颗粒疫苗与“同一健康”方法

Strengthening global health resilience: Marburg virus-like particle vaccines and the One Health approach.

作者信息

Khadka Ram Bahadur, Karki Khimdhoj, Pandey Jitendra, Gyawali Rabin, Chaudhary Gautam Prasad

机构信息

Department of Laboratory Science, Crimson College of Technology, Affiliated with Pokhara University, Butwal-11, Devinagar, Rupandehi 32907, Nepal.

Department of Chemistry, University of Hawaii at Manoa, Honolulu, HI, USA.

出版信息

Sci One Health. 2024 Aug 10;3:100076. doi: 10.1016/j.soh.2024.100076. eCollection 2024.

DOI:10.1016/j.soh.2024.100076
PMID:39309209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415973/
Abstract

The Marburg virus (MARV), belonging to the family, poses a significant global health threat, emphasizing the urgency to develop Marburg virus-like particle (VLP) vaccines for outbreak mitigation. The virus's menacing traits accentuate the need for such vaccines, which can be addressed by VLPs that mimic its structure safely, potentially overcoming past limitations. Early Marburg vaccine endeavors and their challenges are examined in the historical perspectives section, followed by an exploration of VLPs as transformative tools, capable of eliciting immune responses without conventional risks. Noteworthy milestones and achievements in Marburg VLP vaccine development, seen through preclinical and clinical trials, indicate potential cross-protection. Ongoing challenges, encompassing durability, strain diversity, and equitable distribution, are addressed, with proposed innovations like novel adjuvant, mRNA technology, and structure-based design poised to enhance Marburg VLP vaccines. This review highlights the transformative potential of Marburg VLPs in countering the virus, showcasing global collaboration, regulatory roles, and health equity for a safer future through the harmonious interplay of science, regulation, and global efforts.

摘要

马尔堡病毒(MARV)属于丝状病毒科,对全球健康构成重大威胁,这凸显了开发马尔堡病毒样颗粒(VLP)疫苗以缓解疫情的紧迫性。该病毒的危险特性凸显了此类疫苗的必要性,而VLP可以安全地模拟其结构,有可能克服以往的局限性,从而满足这一需求。在历史视角部分,我们审视了早期马尔堡疫苗的研发工作及其面临的挑战,随后探讨了VLP作为变革性工具的作用,它能够引发免疫反应且不存在传统风险。通过临床前和临床试验可以看到,马尔堡VLP疫苗研发过程中的显著里程碑和成就表明其具有潜在的交叉保护作用。文中还讨论了当前面临的挑战,包括疫苗持久性、毒株多样性和公平分配等问题,并提出了一些创新方法,如新型佐剂、mRNA技术和基于结构的设计,有望增强马尔堡VLP疫苗的效果。本综述强调了马尔堡VLP在对抗该病毒方面的变革潜力,展示了全球合作、监管作用以及通过科学、监管和全球努力的和谐互动实现更安全未来的健康公平性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7e/11415973/05a3dc45fe2b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7e/11415973/05a3dc45fe2b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7e/11415973/05a3dc45fe2b/gr1.jpg

相似文献

1
Strengthening global health resilience: Marburg virus-like particle vaccines and the One Health approach.加强全球卫生韧性:马尔堡病毒样颗粒疫苗与“同一健康”方法
Sci One Health. 2024 Aug 10;3:100076. doi: 10.1016/j.soh.2024.100076. eCollection 2024.
2
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).病毒样颗粒疫苗接种可保护非人灵长类动物免受马尔堡病毒致死性气溶胶暴露(病毒样颗粒疫苗接种保护猕猴免受气溶胶攻击)。
Viruses. 2016 Apr 8;8(4):94. doi: 10.3390/v8040094.
3
A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.双价、球形病毒样颗粒疫苗增强恒河猴对致病性埃博拉病毒免疫反应的广度。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.01884-19.
4
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection.表达马尔堡病毒样颗粒的改良安卡拉痘苗病毒疫苗可保护豚鼠免受致死性马尔堡病毒感染。
NPJ Vaccines. 2020 Sep 2;5(1):78. doi: 10.1038/s41541-020-00226-y. eCollection 2020.
5
Advances in virus-like particle vaccines for filoviruses.病毒样颗粒疫苗在丝状病毒中的研究进展。
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1053-9. doi: 10.1093/infdis/jir346.
6
Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.昆虫细胞中产生的马尔堡病毒样颗粒可诱导恒河猴产生中和抗体。
J Med Virol. 2017 Dec;89(12):2069-2074. doi: 10.1002/jmv.24832. Epub 2017 Sep 1.
7
Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice.在昆虫细胞中共表达糖蛋白和基质蛋白产生马尔堡病毒样颗粒可诱导小鼠产生免疫应答。
Virol J. 2017 Oct 25;14(1):204. doi: 10.1186/s12985-017-0869-3.
8
A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.一种表达马尔堡病毒糖蛋白的重组狂犬病病毒依赖于抗体介导的细胞细胞毒性来预防小鼠模型中的马尔堡病毒病。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01865-18. Print 2019 Mar 15.
9
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.单价病毒样颗粒疫苗可保护豚鼠和非人类灵长类动物免受多种马尔堡病毒感染。
Expert Rev Vaccines. 2008 May;7(4):417-29. doi: 10.1586/14760584.7.4.417.
10
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.病毒样颗粒作为针对埃博拉病毒和马尔堡病毒感染的泛丝状病毒疫苗展现出了潜力。
Vaccine. 2005 Apr 27;23(23):3033-42. doi: 10.1016/j.vaccine.2004.11.070.

引用本文的文献

1
Marburg Virus Disease: Epidemiology, Immune Responses, and Innovations in Vaccination and Treatment for Enhanced Public Health Strategies.马尔堡病毒病:流行病学、免疫反应以及疫苗接种与治疗方面的创新以强化公共卫生策略
Pathogens. 2025 May 12;14(5):468. doi: 10.3390/pathogens14050468.
2
Therapeutic advances in Marburg virus disease: from experimental treatments to vaccine development.马尔堡病毒病的治疗进展:从实验性治疗到疫苗研发
Ann Med Surg (Lond). 2025 Mar 28;87(5):2784-2799. doi: 10.1097/MS9.0000000000003213. eCollection 2025 May.

本文引用的文献

1
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.确保 FDA 的可靠性以建立公众对疫苗的信任。
Hastings Cent Rep. 2023 Sep;53 Suppl 2:S60-S68. doi: 10.1002/hast.1525.
2
Update on the Phylodynamic and Genetic Variability of Marburg Virus.马尔堡病毒的系统发育和遗传变异性的最新研究进展。
Viruses. 2023 Aug 11;15(8):1721. doi: 10.3390/v15081721.
3
Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review.马尔堡病毒(MARV)疫苗研究进展及其近期在赤道几内亚和坦桑尼亚的再度出现:一项综述。
Cureus. 2023 Jul 17;15(7):e42014. doi: 10.7759/cureus.42014. eCollection 2023 Jul.
4
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.高减毒痘病毒疫苗用于新发病毒性疾病。
J Mol Biol. 2023 Aug 1;435(15):168173. doi: 10.1016/j.jmb.2023.168173. Epub 2023 Jun 8.
5
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies.抗病毒多克隆抗体和单克隆抗体疗法的用途与挑战
Pharmaceutics. 2023 May 19;15(5):1538. doi: 10.3390/pharmaceutics15051538.
6
Deadly Marburg virus outbreak received sustained attention: What can we learn from the existing studies?致命的马尔堡病毒疫情受到持续关注:我们能从现有研究中学到什么?
Int J Surg. 2023 Aug 1;109(8):2539-2541. doi: 10.1097/JS9.0000000000000443.
7
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.病毒载体疫苗:在人类疾病中的设计、开发、预防和治疗应用。
Signal Transduct Target Ther. 2023 Apr 7;8(1):149. doi: 10.1038/s41392-023-01408-5.
8
Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges.埃博拉病毒病疫苗:研发、当前观点与挑战
Vaccines (Basel). 2023 Jan 26;11(2):268. doi: 10.3390/vaccines11020268.
9
A Review on Zoonotic Pathogens Associated with Non-Human Primates: Understanding the Potential Threats to Humans.非人灵长类动物相关人畜共患病原体综述:了解对人类的潜在威胁
Microorganisms. 2023 Jan 18;11(2):246. doi: 10.3390/microorganisms11020246.
10
Re-emerging of Marburg virus: warning about its virulence and potential impact on world's health.马尔堡病毒的再度出现:对其毒力及对全球健康潜在影响的警示
Int J Surg. 2023 Feb 1;109(2):165-166. doi: 10.1097/JS9.0000000000000162.